Arbor
A Senior Scientist, Pharmacology at Arbor Biotechnologies leads in vivo pharmacology studies for neuroscience gene-editing programs, driving strategy and execution to generate decision-enabling data. The role involves collaborating with cross-functional teams and external CRO partners to analyze molecular and histology readouts while preparing regulatory reports. Additionally, the position includes managing 1-2 research associates to provide scientific guidance and support their professional development.
Headquarters
Uniondale, New York, United States
Company Size
501-1000 employees
Founded
1993
Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily and commercial real estate industries. The firm originates and acquires mortgage loans and structured financing solutions—including agency, bridge, and other capital products—to support property owners and operators. Arbor positions itself as a capital partner for real estate investors, emphasizing tailored lending, active portfolio management, and access to institutional funding sources.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arbor.
Arbor didn’t post a salary, so this is our estimate from similar listings.
14% above the average for this role
Gene Therapy Potency Assay Scientist
meiragtx
Advisor – RNA Preclinical Pharmacology
Eli Lilly and Company
Associate Scientist
Regeneron Pharmaceuticals
Post Doctoral Scholar- Biological Chemistry and Pharmacology
The Ohio State University
Scientist, In Vivo Pharmacology, Neuroscience
Bristol Myers Squibb
Advisor, Preclinical Pharmacology
Eli Lilly and Company